uniQure will run another trial of its Huntington’s Disease gene therapy following the FDA’s review. Credit: Vink Fan / Shutterstock.com uniQure’s stock has dropped by more than 40% after being asked ...

Early signs of functional improvement were recorded, including a 12-letter gain in BCVA in the treated eye. Credit: Mangza2029 / Shutterstock.com. Opus Genetics has reported early findings from its ...

Keytruda is authorised for adjuvant treatment of certain RCC patients in EU, Canada, Japan and the US. Credit: H_Ko / Shutterstock.com. Merck (MSD) has announced findings from the pivotal Phase III ...

Neuromodulation systems are becoming increasingly popular for the treatment of UUI. Credit: designerNFMR / Shutterstock.com. BlueWind Medical’s Revi implantable tibial neuromodulation (ITNM) system ...

Faster and more cost-effective trials support early-stage research in China driving the country's drug discovery engine.

Ahead of Rare Disease Day, Abigail Beaney, editor of Clinical Trials Arena, spoke with Robert Barrie, editor of Pharmaceutical Technology and Frankie Fattorini, reporter for Pharmaceutical Technology ...

Synthekine has entered into a clinical trial partnership and supply agreement with MSD to investigate STK-012 in combination with Keytruda and chemotherapy in patients with first-line, PD-L1 negative ...

Mahzi Therapeutics has dosed the first patient in its Phase I/II UNITE study assessing MZ-1866, an investigational gene ...

For the global Phase III clinical programme, more than 6,000 people with type 2 diabetes were enrolled. Credit: megaflop / Shutterstock.com. Eli Lilly and Company has reported detailed findings from ...

The double-blind, placebo controlled trial enrolled 71 patients with SAD. Credit: Elena Kalinicheva / Shutterstock.com AtaiBeckley’s social anxiety disorder (SAD) drug has shown both safety and early ...

ViiV Healthcare has reported several successful HIV trials at CROI 2026, including its investigational candidates lotivibart, ...